Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Working Capital Changes (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Other Working Capital Changes readings, the most recent being $43.7 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 272.05% to $43.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.4 million, a 44300.0% increase, with the full-year FY2025 number at $44.4 million, up 44300.0% from a year prior.
  • Other Working Capital Changes hit $43.7 million in Q4 2025 for Neurocrine Biosciences, up from $200000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $43.7 million in Q4 2025 to a low of -$25.4 million in Q4 2024.
  • Median Other Working Capital Changes over the past 5 years was $2.4 million (2021), compared with a mean of $3.6 million.
  • The widest YoY moves for Other Working Capital Changes: up 6366.67% in 2024, down 2053.85% in 2024.
  • Neurocrine Biosciences' Other Working Capital Changes stood at $1.5 million in 2021, then tumbled by 333.33% to -$3.5 million in 2022, then surged by 137.14% to $1.3 million in 2023, then plummeted by 2053.85% to -$25.4 million in 2024, then surged by 272.05% to $43.7 million in 2025.
  • The last three reported values for Other Working Capital Changes were $43.7 million (Q4 2025), $200000.0 (Q3 2025), and -$7.4 million (Q2 2025) per Business Quant data.